A world class sterile injectables platform, robust product pipeline and record regulatory filings, multi locational manufacturing facilities, an impeccable record of quality and marquee customers and partners across the healthcare industry have set the trajectory for our rapid growth in the steriles segment, one in which Strides seeks to be a global leader.

Strides’ established presence in more than 70 countries has facilitated the identification of growth trends and niche opportunities in products and formats in anticipation of market demands. We have positioned ourselves to create strategic domains such as oncolytics, penems, pencillins, cephalosporins, ophthalmics, peptides and biologicals that cover large market segments with both near term and long term market introductions.